Log In
Print
BCIQ
Print
Print this Print this
 

Valcyte, Valixa, valganciclovir (R127, RG127)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionProdrug formulation of ganciclovir, a guanine derivative nucleoside analog
Molecular Target Viral polymerase
Mechanism of ActionViral polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent cytomegalovirus (CMV) disease in kidney transplant patients; Prevent cytomegalovirus (CMV) disease in patients who have received a solid organ transplant; Prevent cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients; Treat cytomegalovirus (CMV) retinitis in HIV/AIDS patients
Regulatory Designation

Partner

Mitsubishi Tanabe Pharma Corp.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today